Why the study?
Does atrial antitachycardia pacing safely and effectively convert recurrent atrial tachycardia in patients with repaired congenital heart disease?
Does atrial antitachycardia pacing safely and effectively convert recurrent atrial tachycardia in patients with repaired congenital heart disease?
Atrial antitachycardia pacing can successfully terminate atrial reentry tachycardia in congenital heart disease patients but carries a risk of sudden death during pace cardioversion, warranting careful autonomic stress evaluation prior to use.
Answers are grounded in this paper and cite their sources.
Sudden death during pacing cautions against use in congenital heart disease; leaves open safety and role pending larger studies.
UNLABELLED: Atrial reentry tachycardia is common after surgical repair of congenital heart disease. The arrhythmia is often difficult to treat and is occasionally life-threatening. This study reports experience with atrial antitachycardia (AAIT mode) pacing for the management of atrial reentry tachycardia, with emphasis on the risks and benefits of automatic pacing therapy. Eighteen patients (2-32 years of age) with a variety of congenital heart lesions underwent atrial antitachycardia pacemaker placement for recurrent atrial tachycardia that was amenable to pace termination prior to the implantation procedure. An appropriate antitachycardia program was determined by repeated induction and termination of atrial tachycardia using the noninvasive programmed stimulation mode of the pacemaker. Over 4-30 months of follow-up, 6 patients had 189 episodes of tachycardia successfully converted with AAI-T pacing, 4 patients had 8 episodes of tachycardia detected but not successfully converted, and 8 patients had no episodes of tachycardia with antibradycardia pacing alone. The number of patients receiving pharmacological therapy other than digoxin or beta blockade fell from 12 to 6. Two subjects died suddenly, 1 while wearing a Holter monitor. In both, tachycardia was detected and pace cardioversion attempted. CONCLUSIONS: Atrial antitachycardia pacing is a useful tool in the management of patients with congenital heart disease and atrial arrhythmias; however, in selected cases, it may not prevent and may even exacerbate the lethal complications of the tachycardia. Antitachycardia function evaluation is recommended under varying levels of autonomic stress prior to institution of automatic therapy.
No takes yet. Share an insight, caveat, or question.
Rhodes et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: